Home > Insider Trading > Filing (0001193805-25-000788)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1280776	Immunic Inc.	IMUX	Pharmaceutical Preparations (2834)	562358443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724623	Glenn Whaley	1200 Avenue Of The Americas, Suite 200 New York NY 10036	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-30	25,000	$0.56	50,510	No	5	A	Direct
Common Stock	Acquisiton	2025-06-03	45,000	$0.71	95,510	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	P	Direct

Footnotes

The Reporting Person (RP) is voluntarily reporting the acquisition of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7127 to $0.7134. The RP undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.